kratom varieties or forms. The explanation for this is that kratom extracts have larger quantities of active ingredients: Mitragynine and 7-hydroxymitragynine. Additionally‚ kratom extracts have a smaller amount of substances that work as antagonists. In kratom leaves‚ you will find naturally-present antagonists which connect to the receptors that may otherwise be bound to mitragynine and 7-hydroxymitragynine‚ this process reduces the effects of kratom. However‚ since the kratom extract doesn’t have
Premium Kratom Alkaloid Mitragynine
Based on the research I have presented in this paper‚ I believe it is reasonable to say that kratom presents very little (if any) threat to public health and safety and there is a lack of sufficient evidence‚ historic or scientific‚ to show that kratom presents significant danger despite many years of widespread use. There is not a kratom epidemic. Scheduling kratom under the CSA would only serve to‚ ultimately‚ drain resources from enforcing current drug laws in regulating much more dangerous
Premium Government United States Immunology